Osteomyelitis or myositis ossificans: a diagnosis in disguise in a case of hereditary sensory and autonomic neuropathy type 4

Authors

  • Abdulaziz Matar Department of Orthopedics, Bahrain Defence Force Hospital, Riffa, Bahrain
  • Mohamed Shujaie Department of ENT, Salmaniya Medical Complex, Manama, Bahrain
  • Rola Husain Department of Radiology, Diagnostic and Interventional Musculoskeletal Radiology Consultant, Salmaniya Medical Complex, Manama, Bahrain

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20242406

Keywords:

Hereditary sensory and autonomic neuropathy, Congenital insensitivity to pain with anhidrosis, Self-mutilation, Myositis ossificans, Osteomyelitis

Abstract

Hereditary Sensory and Autonomic Neuropathy Type IV (HSAN-IV), also known as Congenital Insensitivity to Pain with Anhidrosis (CIPA), is an extremely rare condition with loss of peripheral unmyelinated and small myelinated nerve fibres, leading to the absence of pain sensation and inability to sweat. Affected patients require careful care in order to prevent debilitating consequences and potential morbidity as a result of recurrent trauma and self-mutilating behaviour. We report a case of 4 years and 10 months old boy who has been diagnosed with HSAN-IV at 6 months of age, which was confirmed by genetic testing. This study was conducted in the largest tertiary medical complex in the Kingdom of Bahrain. He had multiple hospital presentations with various upper and lower extremity injuries requiring a multidisciplinary approach for different management strategies. The diagnosis can be extremely challenging due to an exhausting list of differential diagnosis and limited number of cases provided in the literature.

References

Kurth I. Hereditary sensory and autonomic neuropathy type IV-symptoms, causes, treatment: Nord. 2023. Available at: https://rarediseases.org/rare-diseases/hereditary. Accessed on 23 April 2024.

Haga N, Kubota M, Miwa Z. Epidemiology of hereditary sensory and autonomic neuropathy type IV and V in Japan. Am J Med Genet A. 2013;161(4):871-4.

Prashanth GP, Kamate M. A case of hereditary sensory autonomic neuropathy type IV. U.S. Ann Indian Acad Neurol. 2012;15(2):134-6.

Azadvari M, Emami Razavi SZ, Kazemi S. Hereditary sensory and autonomic neuropathy type iv in 9-year-old boy: a case report. Iran J Child Neurol. 2016;10(2):83-5.

Tsuruta Indo Y, Hayashida M, Karim Y, Ohta MA, Kawano K, Mitsubuchi T, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet. 1996;13(4):485-8.

Indo Y. Molecular basis of congenital insensitivity to pain with anhidrosis (CIPA): mutations and polymorphisms in TRKA (NTRK1) gene encoding the receptor tyrosine kinase for nerve growth factor. Hum Mutat. 2001;18(6):462-71.

Kwee RM, Kwee TC. Calcified or ossified benign soft tissue lesions that may simulate malignancy. Skeletal Radiology. 2019;48(12):1875-90.

Farooq S. Myositis ossificans. Radiology Reference Article. Radiopaedia.org. Radiopaedia. Available at: https://radiopaedia.org/articles.

Oertel B, Lötsch J. Genetic mutations that prevent pain: implications for future pain medication. Pharmacogenomics. 2008;9(2):179-94.

Franco ML, Melero C, Sarasola E, Acebo P, Luque A, Calatayud-Baselga I, et al. Mutations in TrkA causing congenital insensitivity to pain with anhidrosis (CIPA) induce misfolding, aggregation, and mutation-dependent neurodegeneration by dysfunction of the Autophagic Flux. J Biolog Chem. 2016;291(41):21363-74.

Majid I, Yaseen A. The child who felt no pain: A case of hereditary sensory autonomic neuropathy (HSAN) type IV. Indian J Paed Dermatol. 2014;15(3):140.

Eichler F, Kothari M. Hereditary sensory and autonomic neuropathies. Orphanet J Rare Dis. 2007;2:39.

Kim W, Guinot A, Marleix S, Chapuis M, Fraisse B, Violas P. Hereditary sensory and autonomic neuropathy type IV and orthopaedic complications. Orthop Traumatol Surg Res. 2013;99(7):881-5

Saad A, Azzopardi C, Patel A, Davies AM, Botchu R. Myositis ossificans revisited - The largest reported case series. J Clin Orthop Trauma. 2021;17:123-7.

Walczak BE, Johnson CN, Howe BM. Myositis Ossificans. JAAOS. 2015;23(10):612–22.

Kan L, Kessler JA. Evaluation of the cellular origins of heterotopic ossification. 2014;37(5):329–40.

Sferopoulos NK, Kotakidou R, Petropoulos AS. Myositis ossificans in children: a review. Eur J Orthop Surg Traum. 2017;27(4):491-502.

Kransdorf MJ, Meis JM, Jelinek JS. Myositis ossificans: MR appearance with radiologic-pathologic correlation. Am J Roentgenol. 1991;157(6):1243–8.

Lee KR, Park SY, Jin W, Won KY. MR imaging and ultrasonography findings of early myositis ossificans: a case report. Skeletal Radiol. 2016;45(10):1413–7.

Olvi, L.G., Santini-Araujo, E. Myositis Ossificans. Tumors and tumor-like lesions of bone. Springer. 2015:777-9.

Devilbiss Z, Hess M, Ho GWK. Myositis Ossificans in Sport: A Review. Current Sports Medicine Reports. 2018;17(9):290-5.

Nuovo Margaret A, Norman A, Chumas J, Ackerman LaurenV. Myositis ossificans with atypical clinical, radiographic, or pathologic findings: A review of 23 cases. Skeletal Radiol. 1992;21(2).

Downloads

Published

2024-08-28